A randomised efficacy and discontinuation study of etanercept versus adalimumab (RED SEA) for rheumatoid arthritis: a pragmatic, unblinded, non-inferiority study of first TNF inhibitor use: outcomes over 2 years-Reference-Cited by-同舟云学术

A randomised efficacy and discontinuation study of etanercept versus adalimumab (RED SEA) for rheumatoid arthritis: a pragmatic, unblinded, non-inferiority study of first TNF inhibitor use: outcomes over 2 years

Published:2012 Issue:6 Volume:2 Page:e001395
ISSN:2044-6055
Container-title:BMJ Open
language:en
Short-container-title:BMJ Open

Author:

Jobanputra Paresh,Maggs Fiona,Deeming Alison,Carruthers David,Rankin Elizabeth,Jordan Alison C,Faizal Abdul,Goddard Carolyn,Pugh Mark,Bowman Simon J,Brailsford Sue,Nightingale Peter

Publisher

BMJ

Subject

General Medicine

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of TNF-α inhibitors: A real-world study based on the US FDA Adverse Event Reporting System Database;Medicine;2024-07-19

2. Clinical practice guidelines for the early detection, diagnosis, treatment, and follow-up of patients with rheumatoid arthritis. Colombian Association of Rheumatology, 2022;Revista Colombiana de Reumatología (English Edition);2024-04

3. Guía de práctica clínica para la detección temprana, el diagnóstico, el tratamiento y el seguimiento de los pacientes con artritis reumatoide. Asociación Colombiana de Reumatología, 2022;Revista Colombiana de Reumatología;2023-02

4. Comparative Treatment Persistence with Bone-Targeting Agents Among Asian Patients with Bone Metastases from Solid Tumors: A Multinational Retrospective Cohort Study;BioDrugs;2022-04-12

5. The Risk of Adverse Effects of TNF-α Inhibitors in Patients With Rheumatoid Arthritis: A Network Meta-Analysis;Frontiers in Immunology;2022-02-16